This Government Contract opportunity from Department Of Defense was posted on May 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Supply – Trazodone Tablets (50 mg)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the manufacture, packaging, and supply of Trazodone Hydrochloride 50 mg tablets, ensuring strict adherence to regulatory and military standards including FDA requirements, the Defense Logistics Agency (DLA) protocols, and current Good Manufacturing Practices (cGMP). The production must also comply with ASTM D3951 and MIL-STD-129, which govern packaging and military shipping standards. This subcontract is issued by the Department of Defense's Medical Supply Chain Pharmacy FSA, under the NAICS code 325412, which covers pharmaceutical manufacturing. The solicitation was posted on May 13, 2026, with responses due by May 19, 2026. While specific location details for the place of performance and agency office are not provided, the contract targets suppliers capable of meeting stringent quality and compliance requirements for military pharmaceutical supplies. This procurement supports the reliable and compliant delivery of essential medication to military personnel, reflecting the high standards required for government and defense-related pharmaceuticals.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
